Zimmer Biomet (NYSE: ZBH) announced today that the FDA granted 510(k) clearance for its Rosa Knee surgical robot with ...
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of ROSA® Knee with OptimiZe™, an enhanced ...
ROSA ® Knee with OptimiZe Offers Personalized Surgical Planning and Drives Confidence in Delivering Accurate and Reproducible Outcomes1 WARSAW, Ind., Nov. 14, 2025 /PRNewswire/ -- Zimmer ...
Detailed price information for Zimmer Biomet Holdings (ZBH-N) from The Globe and Mail including charting and trades.
Zimmer Biomet Holdings ((ZBH)) announced an update on their ongoing clinical study.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, ...
Q3 2025 Earnings Call Transcript November 5, 2025 Zimmer Biomet Holdings, Inc. misses on earnings expectations. Reported EPS ...
WARSAW - The U.S. Food and Drug Administration has granted Breakthrough Device Designation to Zimmer Biomet Holdings, Inc.’s (NYSE and SIX:ZBH) iodine-treated total hip replacement system, the company ...
Hospital and Clinic, part of Rochester Regional Health, completed its first Persona IQ Smart Knee device implant. The implant, created by Zimmer Biomet, is used for total knee arthroplasty procedures ...
The Company will conduct its third quarter investor conference call today, November 5, 2025, at 8:30 a.m. ET. The audio webcast can be accessed via Zimmer Biomet's Investor Relations website at https: ...
The global orthopedic implants market is expected to grow at a CAGR of ~4% during the forecast period. Increasing geriatric population, rising incidence of chronic conditions such as osteoarthritis ...
Q1 2026 Earnings Call October 29, 2025 8:01 PM EDTCompany ParticipantsGregory Brown - CEO, MD & DirectorArun Singh ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback